Amgen, Moderna, the Allen Institute, and Thermo Fisher received OpenAI's GPT-Rosalind vertical reasoning model as a research preview for drug discovery and genomics work.
Novo Nordisk partnered with OpenAI to overhaul drug development, with pilots starting immediately in R&D, manufacturing, and commercial and full integration planned by year-end.
Every entry names the organisation and links its source. Outcome figures are quoted as reported, never estimated. Vendor announcements without a named customer are excluded. Halted and reversed deployments are kept on purpose.
Usamos cookies essenciais para o site funcionar (login, segurança dos formulários). Com a sua permissão, também usamos cookies de análise para entender como você usa o site.
Política de privacidade